Outcomes of Hepatitis B Virus Recurrence After Liver Transplantation

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2123-2124

  Han, Y S ^a   Lee, S K ^a   Joh, J W ^a   Kim, S J ^a   Kwon, C H D ^a   Park, J W ^a   Kim, D J ^a   Park, J B ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; SEROCONVERSION; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33846079661     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.032     Document Type: Article

References (4)

1. Steinmuller T., Seehofer D., Rayes N., et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 35 (2002) 1528
2. Guy W.N., Christopher B., O'Brien, et al. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Liver Transpl 10 (2004) 1372
3. Marzano A., Gaia S., Ghisetti V., et al. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Liver Transpl 11 (2005) 402
4. Papatheodoridis G.V., Sevastianos V., and Burroughs A.K. Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era. Am J Transplant 3 (2003) 250